169
Views
40
CrossRef citations to date
0
Altmetric
Research Article

Levels of three inflammation markers, C-reactive protein, serum amyloid A protein and procalcitonin, in the serum and cerebrospinal fluid of patients with meningitis

Pages 567-574 | Published online: 08 Jul 2009

  • Assicot M, Gendrei D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-8.
  • Miwata H, Yamada T, Okada M, Kudo T, Kimura H, Morishima T. Serum amyloid A protein in acute viral infections. Arch Dis Child 1993; 68: 210-4.
  • Livrea P, Torjano M, Simone LI, Zimatore GB, Pisicchio L, Logroscino G, Cibelli G. Heterogeneous models for blood-cerebrospinal fluid barrier permeability to serum proteins in normal and abnormal cerebrospinal fluid/serum protein concentration gradients. J Neurol Sci 1984; 64: 245-58.
  • Shimetani N, Ichikawa K, Ohtani H. Sandwich Enzyme Immunoassay for serum amyloid A protein in cerebrospinal fluid Kitasato Med 1997; 27: 283-7.
  • Kushner I. The phenomenon of the acute phase response. Ann NY Acad Sci 1982; 389: 39-48.
  • Maury CP. Comparative study of serum amyloid A protein and C-reactive protein in disease. J Clin Sei 1985; 68: 233-8.
  • Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15: 74-80.
  • Shimetani N, Ichikawa K, Shibuya M, Mashiko T, Matsuyama N, Kanoh Y, Ohtani H. Quantitative levels of serum amyloid A protein and other proteins in cerebrospinal fluid and serum of patients with meningitis. Jpn J Clin Pathol 1998; 46: 930-5.
  • Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K. Procalcitonin--a new indicator of the systemic response to severe infections. Infection 1997; 25: 329-34.
  • Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997; 40: 1250-6.
  • Mimoz O, Benoist JF, Edouard AR, Assicot M, Bohuon C, Samii K. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 1998; 24: 185-8.
  • Corrall CJ, Pepple JM, Moxon ER, Hughes WT. C-reactive protein in spinal fluid of children with meningitis. J Pediatr 1981; 99: 365-9.
  • Gray BM, Simmonds DR, Mason H, Bamum S, Volanakis JR Quantitative levels of C-reactive protein in cerebrospinal fluid in patients with bacterial meningitis and other conditions. J Pediatr 1986; 108: 665-70.
  • Gershom BE, Briggeman-Mol GJ, Zegher DF. Cerebrospinal fluid C-reactive protein in meningitis: diagnostic value and pathophysiology. Eur J Pediatr 1986; 145: 246-9.
  • Hansson LO, Lindquist L, Linne T, Sego E. Quantitation of C-reactive protein in cerebrospinal fluid and serum by zone immunoelectrophoresis assay (ZIA). J Immunol Meth 1987; 100: 191-5.
  • Gendrel D, Raymond J, Assicot M, Moulin F, Iniguez JL, Lebon P, Bohuon C. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 1997; 24: 1240-2.
  • Bohuon C, Assicot M, Raymond J, Gendrel D. Procalcitonin, a marker of bacterial meningitis in children. Bull Acad Natl Med 1998; 182: 1469-75.
  • Meucci G, Rossi G, Bettini R, Montanaro D, Gironelli L, Voci L, Bianchi F. Laser nephelometric evaluation of albumin, IgG and alpha 2-macroglobulin: applications to the study of alterations of the blood-brain barrier. J Neurol Sci 1993; 118:73-8.
  • Kanoh Y, Ohtani H. Levels of interleukin-6, CRP and alpha 2 macroglobulin in cerebrospinal fluid (CSF) and serum as indicator of blood-CSF barrier damage. Biochim Molec Biol Int 1997; 43: 269-78.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.